BGR-34

BGR-34, short for Blood Glucose Regulator-34, is an Ayurvedic-derived product sold in India as an over-the-counter pill for the management of type 2 diabetes. It was developed in 2015 by two government-owned Indian laboratories and launched commercially in 2016, but it has been tested in only one, modest-sized human trial, and without further clinical trials its efficacy remains unproven. Its manufacturers have refused to acknowledge concerns about its unproven efficacy, and its promotion has relied in part on publication in journals identified as predatory, making it a documented case of a government-backed product marketed with insufficient scientific validation.